Case Study: Labeling Recall Due to Expiry Date Confusion

Fri, 11 Jul 2025 04:36:00 +0000

Expiry date accuracy is a non-negotiable element in pharmaceutical labeling. Even small errors in how shelf life or expiry is printed on packaging can lead to product recalls, regulatory observations, or risk to patient safety. In this case-based insight, we examine a real-world scenario where expiry date confusion resulted in a nationwide recall—and the compliance, communication, and CAPA lessons learned.

Background: Product Overview and Timeline

The incident occurred at a mid-sized generic drug manufacturer supplying solid oral dosage forms to the US and European markets. The product in question was an antihypertensive tablet with an approved shelf life of 24 months.

Timeline:

📅 Stability data supported a shelf life of 24 months
📅 Regulatory approval granted with expiry date calculated as “MFG + 24 months”
📅 Product launched in multiple batches across two continents

The manufacturer followed standard GMP protocols—yet still faced a recall due to a simple labeling oversight.

The Problem: Expiry Format vs Regulatory Expectation

During a routine market inspection by a distributor, it was discovered that the printed expiry date on cartons showed “12/2025”, while the actual expiry date based on production date should have been “11/2025”.

Cause: The company’s labeling software rounded the month up when the production date was 30/11/2023. Although the internal systems marked the correct 24-month shelf life, the printed label was off by one month.

Regulatory Response

On reporting this deviation to USFDA and EMA, the issue was classified as a labeling error impacting patient use. Although quality was unaffected, the agencies required immediate action:

❌ A voluntary Class II recall was initiated
❌ A market withdrawal notice was issued to pharmacies
❌ Batch traceability documentation had to be submitted within 5 days

This minor discrepancy caused major operational and reputational consequences.

Root Cause Analysis (RCA)

The RCA team identified multiple contributing factors:

❌ Label printing software defaulted to rounding expiry to next month
❌ QA approval relied on on-screen review, not printed sample
❌ Lack of integration between ERP expiry logic and label generation

The issue was not detected during label review, leading to distribution of incorrectly labeled stock.

CAPA Implementation

Corrective and preventive actions were immediately implemented:

✅ Updated label generation software to use fixed expiry calculation format
✅ Introduced physical label proofing as part of QA release
✅ Added an expiry verification checkpoint to packaging line clearance SOP
✅ Retrained staff across labeling, QA, and packaging functions

These actions helped rebuild trust with regulatory authorities and prevent recurrence.

Lessons Learned

This case illustrates how even compliant processes can fail if individual steps are not integrated and verified. Key takeaways include:

✅ Never rely solely on digital systems—always perform physical label checks
✅ Ensure expiry logic in ERP is consistent with packaging software
✅ Document label verification in QA batch records
✅ Keep cross-functional SOPs synchronized—QA, RA, Packaging, IT

Such steps could have prevented a costly and avoidable recall.

Expiry Verification Checklist for Packaging Teams

Implement the following checklist to avoid expiry-related labeling recalls:

✅ Is the expiry correctly calculated based on production date?
✅ Is the format compliant with country-specific regulations (e.g., MM/YYYY)?
✅ Is the label sample approved by QA in hard copy format?
✅ Does the printed label match ERP batch record expiry?
✅ Has the packaging line performed reconciliation post-print?

This checklist must be embedded into SOP writing in pharma related to product release.

Cross-Functional Responsibility Matrix

Department	Expiry Responsibility
QA	Final label approval, reconciliation, deviation control
Packaging	Label application, physical verification, reconciliation
IT	Label software expiry logic configuration
Regulatory Affairs	Ensure compliance with country-specific expiry requirements

Consequences of Ignoring Expiry Control

❌ Regulatory observations (Form 483, CAPA enforcement)
❌ Market withdrawals and product wastage
❌ Reputational damage with pharmacies and HCPs
❌ Delays in future regulatory approvals

All of which are preventable with a robust expiry documentation and label control program.

Conclusion

This case study underscores the importance of precise expiry labeling and the need for integrated QA-packaging systems. While technical in nature, expiry date confusion is often rooted in simple oversight or lack of cross-functional checks.

With clear SOPs, consistent label verification, and well-trained teams, companies can avoid costly recalls and maintain trust with regulators and patients.

pharma labeling error – StabilityStudies.in